Donor lung pretreatment with prostaglandin E1 does not improve lung graft preservation

European Surgical Research

Volumn 31, Issue 5, 1999, Pages 429-436

  Vainikka, Tiina ^a   Heikkila L ^a   Kukkonen, Sinikka ^a   Toivonen, H ^a   Verkkala, K ^a   Mattila, S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Early graft dysfunction; Ischemia reperfusion injury; Lung transplantation; Prostaglandin E1

Indexed keywords

EURO COLLINS SOLUTION; PROSTAGLANDIN E1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; EXTRACORPOREAL CIRCULATION; GRAFT SURVIVAL; LUNG BLOOD FLOW; LUNG GAS EXCHANGE; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SWINE;

ALPROSTADIL; ANIMALS; CRYOPRESERVATION; HEMODYNAMIC PROCESSES; LUNG; LUNG TRANSPLANTATION; PREMEDICATION; PULMONARY CIRCULATION; PULMONARY GAS EXCHANGE; SWINE; TISSUE DONORS; VASCULAR RESISTANCE;

EID: 0032843543     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008722     Document Type: Article

References (16)

1. Kimblad PO, Sjöberg T, Massa G, Solem J-O, Steen S: High potassium contents in organ preservation solutions cause strong pulmonary vasoconstriction. Ann Thorac Surg 1991;52:523-528.
2. Delima NF, Binns OAR, Buchanan SA, Mauney MC, Cope JT, Shockey KS, Tribble CG, Kron IL: Euro-Collins solution exacerbates lung injury in the setting of high-flow reperfusion. J Thorac Cardiovasc Surg 1996;112:111-116.
3. Delima NF, Binns OAR, Buchanan SA, Cope JT, Mauney MC, Shockey KS, Tribble CG, Kron IL: Low-potassium solution for lung preservation in setting of high-flow reperfusion. Ann Thorac Surg 1996;61:973-976.
4. 1 in twelve-hour lung preservation. J Heart Lung Transplant 1991;10:310-316.
5. Novick RJ, Reid KR, Denning L, Duplan J, Menkis AH, McKenzie FN: Prolonged preservation of canine allografts: The role of prostaglandins. Ann Thorac Surg 1991;51:853-859.
6. 1 or prostacyclin in Euro-Collins solution fails to improve lung preservation. Ann Thorac Surg 1995;60:1617-1622.
7. 1 are blunted after experimental single lung transplantation. J Heart Lung Transplant 1995;14:280-288.
8. 1 infusion. J Thorac Cardiovasc Surg 1992;104:83-89.
9. 2 and leukotrienes; in Gilman AG, Goodman LS, Rall TW, Murad F (eds): The Pharmacological Basis of Therapeutics. New York, Mac Millan, 1985:660-673.
10. Novick RJ, Menkis AH, McKenzie FN: New trends in lung preservation: A collective review. J Heart Lung Transplant 1992;11:377-392.
11. Hooper TL, Thomson DS, Jones MT, Cook L, Owen S, Wilkes S, Woodcock A, Webster AH, Hasleton P, Campbell CS, Rahman AN, McGregor CGA: Amelioration of lung ischemic injury with prostacyclin. Transplantation 1990;49:1031-1035.
12. 1 after lung transplantation improves early graft function. Ann Thorac Surg 1994;58:655-661.
13. 1. Am Rev Respir Dis 1993;148:882-889.
14. 1 as donor pretreatment in a primate model of heart-lung transplantation. J Thorac Cardiovasc Surg 1993;105:965-971.
15. Hooper TL, Fetherston GJ, Frencknell PA, Dark JH, McGregor CGA: The use of a prostacyclin analog, Iloprost, as an adjunct to pulmonary preservation with Euro-Collins solution. Transplantation 1990;49:495-499.
16. 1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension. Crit Care Med 1991;19:60-67.